TY - JOUR T1 - Nested PCR for the detection of <em>Taenia solium</em> DNA in stool samples JF - medRxiv DO - 10.1101/2020.06.29.20142950 SP - 2020.06.29.20142950 AU - C Franco-Muñoz AU - A Arévalo AU - S Duque-Beltran Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/01/2020.06.29.20142950.abstract N2 - The traditional parasitological method to diagnose taeniasis is the microscopic observation of eggs in stool samples. However, this method does not allow differentiation between Taenia saginata and Taenia solium. This aim of this study was to achieve the detection of T. solium DNA by polymerase chain reaction (PCR) and to evaluate the cross-reaction with other species of the genus Taenia and other intestinal parasites. DNA was extracted from adult T. solium cestodes by cryolysis in liquid nitrogen and with the DNA stool extraction kit from Qiagen. The detection limit of the test was evaluated by DNA dilutions in water and in stool samples. DNA was extracted from proglottids of T. saginata and T. crassiceps and from stool samples containing other intestinal parasites using ethanol treatment, alkaline lysis, and the DNA stool extraction kit. Nested PCR was used to amplify a previously described fragment of the Tso31 gene, and the PCR products were analyzed by electrophoresis in 2% agarose gels followed by staining with GelRed. The nested PCR of the Tso31 gene allowed the detection of T. solium DNA in stool samples with a detection limit of 20 pg of parasite DNA. PCR showed no cross-reaction with T. saginata, T. crassiceps, or other intestinal parasites of public health importance in Colombia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Health Institute Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved and monitored by the Ethics Committee of the National Health Institute of Colombia in accordance with national regulations and the Declaration of Helsinki. The patients signed an informed consent statement for the use of the stool sample. The animal experiments were performed following the regulations and ethical codes of the Barrier Bioterium and Experimentation BSL2 of the National Institute of Health of Colombia (Declaration of Helsinki) and according to the three principles of laboratory animal experimentation (reduce, refine, replace).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available in the final publication and on request with the authors of the manuscript ER -